Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Needham Initiates Coverage On Sight Sciences with Hold Rating

Needham Initiates Coverage On Sight Sciences with Hold Rating

Needham analyst David Saxon initiates coverage on Sight Sciences (NASDAQ:SGHT) with a Hold rating.

byBenzinga Newsdesk

October 4, 2022

1 minute read

Needham analyst David Saxon initiates coverage on Sight Sciences (NASDAQ:SGHT) with a Hold rating.

LightInTheBox Stock Gains As Q3 Revenue Breezes Past Expectations

By Shivani Kumaresan

November 25, 10:53 AM

LightInTheBox Holding Co Ltd (NYSE:LITB) reported third-quarter FY22 sales growth of 22.6% year-on-year to $121 million, beating the consensus of $78.49…

LITB

Analyst Ratings

Where ZIM Integrated Shipping Stands With Analysts

By Benzinga Insights

December 5, 9:00 AM

Within the last quarter, ZIM Integrated Shipping (NYSE:ZIM) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent…

ZIM

FDA
News

Amneal Pharmaceuticals Granted FDA Orange Book Approval For VASOPRESSIN

By Benzinga Newsdesk

August 9, 3:23 PM

https://www.accessdata.fda.gov/scripts/cder/ob/results_product.cfm?Appl_Type=A&Appl_No=212944#181

AMRX

IQVIA’s Bold Merger Move Blocked As FTC’s Concerns Over Competition Take Center Stage

By Nabaparna Bhattacharya

January 2, 7:55 AM

IQVIA Holdings, Inc.'s (NYSE: IQV) attempt to acquire DeepIntent, a healthcare advertising firm, was reportedly thwarted as a U.S.

IQV

Needham Initiates Coverage On Sight Sciences with Hold Rating

Related Posts

LightInTheBox Stock Gains As Q3 Revenue Breezes Past Expectations

Where ZIM Integrated Shipping Stands With Analysts

Amneal Pharmaceuticals Granted FDA Orange Book Approval For VASOPRESSIN

IQVIA’s Bold Merger Move Blocked As FTC’s Concerns Over Competition Take Center Stage